Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.
about
Development of the first oligonucleotide microarray for global gene expression profiling in guinea pigs: defining the transcription signature of infectious diseasesEfficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lungApurinic/apyrimidinic endonucleases of Mycobacterium tuberculosis protect against DNA damage but are dispensable for the growth of the pathogen in guinea pigs.bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.Latency antigen α-crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokinesA booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice.rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in miceA new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.Recombinant BCG as a vaccine vehicle to protect against tuberculosis.Secreted acid phosphatase (SapM) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in guinea pig tissuesSecretory phosphatases deficient mutant of Mycobacterium tuberculosis imparts protection at the primary site of infection in guinea pigs.Iron storage proteins are essential for the survival and pathogenesis of Mycobacterium tuberculosis in THP-1 macrophages and the guinea pig model of infectionLive attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B.Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation.KefB inhibits phagosomal acidification but its role is unrelated to M. tuberculosis survival in host.Boosting BCG to protect against TB.A review of murine models of latent tuberculosis infection.Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting MemoryDisruption of mycobactin biosynthesis leads to attenuation of Mycobacterium tuberculosis for growth and virulence.Adjunctive immunotherapy with α-crystallin based DNA vaccination reduces Tuberculosis chemotherapy period in chronically infected mice.Recombinant Invasive Lactococcus lactis Carrying a DNA Vaccine Coding the Ag85A Antigen Increases INF-γ, IL-6, and TNF-α Cytokines after Intranasal Immunization.
P2860
Q28389922-49A006EF-9429-43EE-B4A1-B7C90CECD8E4Q28481571-FCD628FE-BF87-4633-97E7-24B927890FE8Q33573490-812F9EE8-F836-4BAF-9F24-2E3107034896Q33848397-0167C7CB-2C22-4566-80FF-9394C1F397BAQ33886491-1560A2DB-8866-4F25-BBE2-B7EBA42FDD39Q33999520-F1868CEF-7EC9-45BD-B88D-AA344585BB76Q34053027-57A63CE7-0F14-4871-B389-CA21A4728F22Q34298426-E71BF646-C27C-48BA-B09F-A5C8C71E7BD7Q34309667-C3FB63B6-83FA-459A-8147-852D41F33429Q34513982-77E7A7C0-0AB8-4C30-BA55-5CDC7655DB57Q34518560-AF02E9EF-CD7C-4F9F-90D5-2A9F10343B2CQ34907035-69CE00CF-1719-4917-9E23-F3292E1E00DEQ35035800-90C971B9-1CBB-46E0-A705-16839F23A3EAQ35688849-6604C0B1-6C9A-4306-97D9-4BEC8B534571Q35689518-6FFDF2DC-0B19-4E7B-81B1-9A2D1CEC8F1CQ35915369-4C9B4B44-3B2A-47D2-9A90-18865EDF51CAQ36145657-D2AB2965-20CF-4FD7-9483-705AD9DE1884Q36941463-D48C1EDA-3819-4559-B3B4-737A48C2B42BQ37400207-A7CD469B-8D44-42D6-8E00-4FE5003445BCQ37762830-4AA3CA50-1E06-4852-9037-C7DF6D0AE79AQ37926592-A8E7D186-4F95-4217-9898-52FCEBC50E1FQ38207991-8DC46686-F85F-4DA3-87DE-1C8540717DA3Q39136936-243EA517-2576-47CD-874C-F88D437562DAQ40608583-B22FB6D8-429F-4B83-A962-B693B612FDD0Q40974795-01035D47-3E06-40F7-84A7-6720FDC4B973
P2860
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Enhanced and enduring protecti ...... n of cytokine profile in lung.
@ast
Enhanced and enduring protecti ...... n of cytokine profile in lung.
@en
type
label
Enhanced and enduring protecti ...... n of cytokine profile in lung.
@ast
Enhanced and enduring protecti ...... n of cytokine profile in lung.
@en
prefLabel
Enhanced and enduring protecti ...... n of cytokine profile in lung.
@ast
Enhanced and enduring protecti ...... n of cytokine profile in lung.
@en
P2093
P2860
P1433
P1476
Enhanced and enduring protecti ...... n of cytokine profile in lung.
@en
P2093
Anil K Tyagi
Ramandeep Singh
Ruchi Jain
Umesh D Gupta
V D Ramanathan
V M Katoch
P2860
P356
10.1371/JOURNAL.PONE.0003869
P407
P577
2008-12-04T00:00:00Z